Skip to Main Content
Capabilities / Pharmaceutical Manufacturers

Pharmaceutical Manufacturers

Dispensing comprehensive counsel.

Husch Blackwell attorneys advise manufacturers of prescription and over-the-counter products, as well as other stakeholders in the drug supply chain, on matters ranging from regulatory compliance to litigation. Drawing on our technical know-how and industry insights, we help clients position themselves to best advantage under existing laws and policies, while working to shape new policies that reflect today’s complex economic realities.

Our team counsels clients on Food and Drug Administration (FDA) regulatory issues such as post-market reporting obligations, product recalls, product labeling, establishment registration, compliance plans, and product sales and distribution requirements. Additionally, we advocate for pharmaceutical clients in class action and multidistrict litigation, claims for disgorgement of profits, government investigations, whistleblower claims and actions by health insurers.

News Releases | October 15, 2021
Husch Blackwell Scores Victory for Sigmapharm in Hatch-Waxman Litigation

Husch Blackwell successfully defended Sigmapharm Laboratories, LLC in connection with its application for approval of a generic version of the antidepressant vortioxetine.

Testimonial Tina Guilder, CEO, Virtus Pharmaceuticals

“The Husch Blackwell attorneys were fierce and tireless advocates for Virtus. In the face of aggressive actions by our competitors and FDA regulators, they developed and executed a legal plan that protected an important market for us. They have my gratitude and highest recommendation.”

Read how invested partnerships make a difference
Client Results

Husch Blackwell's seasoned team leads clients forward.

See examples from previous projects

Stay updated.

Subscribe to receive Husch Blackwell’s news and insights.

Select your preferences